1. Home
  2. SPRY vs QNST Comparison

SPRY vs QNST Comparison

Compare SPRY & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • QNST
  • Stock Information
  • Founded
  • SPRY 2015
  • QNST 1999
  • Country
  • SPRY United States
  • QNST United States
  • Employees
  • SPRY N/A
  • QNST N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • QNST Business Services
  • Sector
  • SPRY Health Care
  • QNST Consumer Discretionary
  • Exchange
  • SPRY Nasdaq
  • QNST Nasdaq
  • Market Cap
  • SPRY 1.2B
  • QNST 1.1B
  • IPO Year
  • SPRY N/A
  • QNST 2010
  • Fundamental
  • Price
  • SPRY $14.88
  • QNST $16.07
  • Analyst Decision
  • SPRY Strong Buy
  • QNST Strong Buy
  • Analyst Count
  • SPRY 4
  • QNST 7
  • Target Price
  • SPRY $28.75
  • QNST $28.86
  • AVG Volume (30 Days)
  • SPRY 2.2M
  • QNST 651.0K
  • Earning Date
  • SPRY 05-08-2025
  • QNST 05-07-2025
  • Dividend Yield
  • SPRY N/A
  • QNST N/A
  • EPS Growth
  • SPRY N/A
  • QNST N/A
  • EPS
  • SPRY 0.08
  • QNST N/A
  • Revenue
  • SPRY $89,149,000.00
  • QNST $928,723,000.00
  • Revenue This Year
  • SPRY $1.49
  • QNST $80.76
  • Revenue Next Year
  • SPRY $141.68
  • QNST $9.11
  • P/E Ratio
  • SPRY $186.00
  • QNST N/A
  • Revenue Growth
  • SPRY 297063.34
  • QNST 68.98
  • 52 Week Low
  • SPRY $7.55
  • QNST $14.39
  • 52 Week High
  • SPRY $18.51
  • QNST $26.27
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 66.37
  • QNST 41.36
  • Support Level
  • SPRY $11.80
  • QNST $14.95
  • Resistance Level
  • SPRY $15.12
  • QNST $16.48
  • Average True Range (ATR)
  • SPRY 1.04
  • QNST 1.17
  • MACD
  • SPRY 0.20
  • QNST 0.05
  • Stochastic Oscillator
  • SPRY 92.77
  • QNST 41.58

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.

Share on Social Networks: